Look At Analyst Expectations For A Better Read On Clover Health Investments Corp (NASDAQ: CLOV)
Currently, there are 393.27M common shares owned by the public and among those 375.34M shares have been available to trade. The company’s stock has a 5-day price change of -6.08% and 127.87% over the past three months. CLOV shares are trading 191.99% year to date (YTD), with the 12-month market performance up to 157.41% higher. […]
Uncovering Institutional Buying In Clover Health Investments Corp (NASDAQ: CLOV)
Currently, there are 393.27M common shares owned by the public and among those 375.34M shares have been available to trade. The company’s stock has a 5-day price change of -4.21% and 125.95% over the past three months. CLOV shares are trading 210.89% year to date (YTD), with the 12-month market performance up to 169.09% higher. […]
Clover Health Investments Corp (NASDAQ: CLOV) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 381.93M common shares owned by the public and among those 369.53M shares have been available to trade. Insiders at the company have transacted a total of 33 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 13 of these insider trades were purchases, […]
Clover Health Investments Corp (NASDAQ: CLOV) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 381.93M common shares owned by the public and among those 369.84M shares have been available to trade. Insiders at the company have transacted a total of 33 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 13 of these insider trades were purchases, […]
Value Hunters: Look To Clover Health Investments Corp (CLOV)
Currently, there are 381.93M common shares owned by the public and among those 369.84M shares have been available to trade. Insiders at the company have transacted a total of 33 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 13 of these insider trades were purchases, […]
Some Investing Thoughts On Clover Health Investments Corp (NASDAQ: CLOV)
Clover Health Investments Corp (CLOV) concluded trading on Wednesday at a closing price of $0.96, with 5.66 million shares of worth about $5.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.29% during that period and on Wednesday, January 31 the price saw […]
Uncovering Institutional Buying In Clover Health Investments Corp (NASDAQ: CLOV)
Renaissance Technologies LLC recently announced the acquisition of new stake in Clover Health Investments Corp (NASDAQ:CLOV). The institutional investor has increased its shareholding in the Healthcare company by 17.63% to 10.41 million shares with purchase of 1.56 million shares. This fresh investment now brings its stake to 2.60% valued currently at $9.91 million. In addition, […]
Clover Health Investments Corp (NASDAQ: CLOV): Hunting Genuine Value In Market Debris
Renaissance Technologies LLC recently announced the acquisition of new stake in Clover Health Investments Corp (NASDAQ:CLOV). The institutional investor has increased its shareholding in the Healthcare company by 17.63% to 10.41 million shares with purchase of 1.56 million shares. This fresh investment now brings its stake to 2.60% valued currently at $9.59 million. In addition, […]
Growing Through Challenges? – Clover Health Investments Corp (CLOV)
Renaissance Technologies LLC recently announced the acquisition of new stake in Clover Health Investments Corp (NASDAQ:CLOV). The institutional investor has increased its shareholding in the Healthcare company by 17.63% to 10.41 million shares with purchase of 1.56 million shares. This fresh investment now brings its stake to 2.60% valued currently at $9.59 million. In addition, […]
Clover Health Investments Corp (CLOV) Volatility Spurs A Quest For Clarity
Renaissance Technologies LLC recently announced the acquisition of new stake in Clover Health Investments Corp (NASDAQ:CLOV). The institutional investor has increased its shareholding in the Healthcare company by 17.63% to 10.41 million shares with purchase of 1.56 million shares. This fresh investment now brings its stake to 2.60% valued currently at $9.59 million. In addition, […]
